Insulin sensitivity was lower in the morbid obesity/obesity group in comparison with the normal-BMI group initially and annually, as evidenced by insulin, HbA1C, and HOMA-IR levels. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.